Table 3 Clinical course and outcome between ESB patients and Non-bleeding patients.
Variable | ESB Group (n = 24) | Non-bleeding Group (n = 24) | P Value |
|---|---|---|---|
IPN, no. (%) | 19 (79.2) | 15 (62.5) | NS (0.204) |
Digestive tract fistula, no. (%) | 10 (41.7) | 6 (25.0) | NS (0.221) |
SVT, no. (%) | 5 (20.8) | 5 (20.8) | NS (1) |
ACS, no. (%) | 7 (29.2) | 0 (0) | 0.004 |
Organ failure | |||
Shock, no. (%) | 16 (66.7) | 8 (33.3) | 0.021 |
ARDS, no. (%) | 19 (79.2) | 15 (62.5) | NS (0.204) |
AKI, no. (%) | 17 (70.8) | 10 (41.6) | 0.042 |
ALI, no. (%) | 13 (54.2) | 6 (25.0) | 0.039 |
MODS, no. (%) | 18 (75.0) | 8 (33.3) | 0.004 |
Management | |||
CRRT, no. (%) | 16 (66.7) | 8 (33.3) | 0.021 |
PCD, no. (%) | 20 (83.3) | 13 (54.2) | 0.029 |
NPI, no. (%) | 18 (75.0) | 8 (33.3) | 0.004 |
ED, no. (%) | 11 (45.8) | 8 (33.3) | NS (0.376) |
DSA, no. (%) | 17 (70.8) | 5 (20.8) | 0.001 |
Laparotomy, no. (%) | 12 (50.0) | 6 (25.0) | NS (0.074) |
Revised Atlanta classification | 0.001 | ||
Mild, no. (%) | 0 (0) | 0 (0) | |
Moderate severe, no. (%) | 2 (8.3) | 13 (54.2) | |
Severe, no. (%) | 22 (91.7) | 11 (45.8) | |
Mortality, no. (%) | 13 (54.2) | 5 (20.8) | 0.017 |
Hospital duration, days | 35 (19.5–83.75) | 13.5 (8–64.5) | NS (0.060) |
ICU duration, days | 24.5 (12.75–46.25) | 9 (4.25–33.75) | 0.042 |
Cost, thousand CNY | 293 (183–459) | 120 (49–449) | 0.026 |
